Work

Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors

Year: 2026

Type: article

Study design: Observational Study

Source: Expert Review of Anticancer Therapy

DOI: 10.1080/14737140.2026.2733826

Authors: Salih Karatlı, Doğan Yazılıtaş, Mustafa Altınbaş

Institution: Ankara Etlik City Hospital

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7212849290

FWCI:

Cites: 20

Cited by:

Related to: